Perioral dermatitis: nuances of the clinical picture and therapy in different age periods
- Authors: Letyaeva O.I.1, Trapeznikova T.V.2, Gubina V.O.1
-
Affiliations:
- South Ural State Medical University
- LINLINE Clinic LLC
- Issue: Vol 100, No 2 (2024)
- Pages: 96-103
- Section: CLINICAL CASE REPORTS
- URL: https://journals.rcsi.science/0042-4609/article/view/262110
- DOI: https://doi.org/10.25208/vdv14868
- ID: 262110
Cite item
Full Text
Abstract
Perioral dermatitis is a common dermatosis that predominantly affects women aged 25–40 but is also observed in children and adolescents. The distinct localization of this condition in the perioral, perinasal, and periocular zones contributes to apparent psycho-emotional distress, markedly impairing patients’ quality of life. Perturbations in the skin biotope, local immune dysregulation, and topical glucocorticosteroid use are among the primary etiological factors. Effective management involves addressing causative factors, discontinuation of topical steroids, adopting gentle skincare practices, and employing localized treatments like metronidazole, pimcrolimus, and activated zinc pyrithione. Maintenance therapy may be warranted in select cases. The purpose of this work is to review the current literature on the problem and to present original clinical observations concerning the utilization of activated zinc pyrithione in treating patients with this condition. The article presents the results of the use of topical activated zinc pyrithione in patients spanning various age groups and exhibiting diverse degrees of perioral dermatitis severity. Significant clinical evidence substantiates the remarkable efficacy and safety profile of activated zinc pyrithione in managing perioral dermatitis, both as a standalone therapeutic modality and as an integral component of combination therapy. The use of activated zinc pyrithione in the treatment of perioral dermatitis emerges as an efficacious and secure approach for treating mild to moderate forms of the condition.
Full Text
##article.viewOnOriginalSite##About the authors
Olga I. Letyaeva
South Ural State Medical University
Author for correspondence.
Email: olga-letyaeva@yandex.ru
ORCID iD: 0000-0002-9085-6229
SPIN-code: 3312-3150
MD, Dr. Sci. (Med.), Professor
Russian Federation, ChelyabinskTatyana V. Trapeznikova
LINLINE Clinic LLC
Email: tayana_tr@mail.ru
ORCID iD: 0000-0001-9757-418X
SPIN-code: 9908-8715
MD, Cand. Sci. (Med.)
Russian Federation, ChelyabinskValeria O. Gubina
South Ural State Medical University
Email: lerushka-98@mail.ru
ORCID iD: 0000-0002-8523-8274
SPIN-code: 3441-8556
Russian Federation, Chelyabinsk
References
- Mihan R, Ayres S. Perioral dermatitis. Arch Dermatol. 1964;89:803–805. doi: 10.1001/archderm.1964.01590300031010
- Периоральный дерматит: Клинические рекомендации. РОДВК; 2020 (проект). URL: https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020/
- Goel NS, Burkhart CN, Morrell DS. Pediatric periorificial dermatitis: Clinical course and treatment outcomes in 222 patients. Pediatr Dermatol. 2015;32(3):333–336. doi: 10.1111/pde.12534
- Hajar T, Leshem YA, Hanifin JM, Nedorost ST, Lio PA, Paller AS, et al. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541–549. doi: 10.1016/j.jaad.2014.11.024
- Zheng Y, Wang Q, Ma L, Chen Y, Gao Y, Zhang G, et al. Alterations in the skin microbiome are associated with disease severity and treatment in the perioral zone of the skin of infants with atopic dermatitis. Eur J Clin Microbiol Infect Dis. 2019;38(9):1677–1685. doi: 10.1007/s10096-019-03598-9
- Kellen R, Silverberg NB. Pediatric periorificial dermatitis. Cutis. 2017;100(6):385–388.
- Milagre ACX, Almeida APMd, Rezende HD, Almeida LMd, Peçanha MAP. Granulomatous perioral dermatitis with extra-facial involvement in childhood: Good therapeutic response with oral azithromycin. Rev Paul Pediatr. 2018;36(4):511–514. doi: 10.1590/1984-0462/;2018;36;4;00004
- SearleT, Ali FR, Al-Niaimi F. Perioraldermatitis: Diagnosis, proposedetiologies, andmanagement. J Cosmet Dermatol. 2021;20(12):3839–3848. doi: 10.1111/jocd.14060
- Адаскевич В.П., Мяделец М.О. Клинико-патогенетические варианты периорального дерматита. Дерматовенерология. Косметология. 2017;3(3):278–291. [Adaskevich VP, Myadelec MO. Kliniko-patogeneticheskie varianty perioral’nogo dermatita. Dermatovenerologiya. Kosmetologiya. 2017;3(3):278–291. (In Russ.)]
- Патрушев А.В., Сухарев А.В., Иванов А.М., и др. Теория очаговой инфекции: прошлое и настоящее. Вестник дерматологии и венерологии. 2015;91(4):36–41. [Patrushev AV, Suharev AV, Ivanov AM, et al. Focal infection theory: past and present. Vestnik Dermatologii i Venerologii. 2015;91(4):36–41. (In Russ.)] doi: 10.25208/0042-4609-2015-91-4-36-41
- Pang M, Yao Z, Chen C, Lei X, Cheng B. Human-microorganism mutualism theory: Possible mechanisms for the delayed chronic wound healing process. Med Hypotheses. 2020;141:109720. doi: 10.1016/j.mehy.2020.109720
- Летяева О.И. Роль инфекционных агентов в патогенезе дерматозов у детей и подростков. Детские инфекции. 2020;19(3):58–64. [Letyaeva OI. The role of infectious agents in the pathogenesis of dermatoses in children and adolescents. Children Infections. 2020;19(3):58–64. (In Russ.)] doi: 10.22627/2072-8107-2020-19-3-58-64
- Вашкевич А.А., Суворова А.А., Разнатовский К.И., Резцова П.А., Гулордава М.Д., Левина Ю.В. Периоральный дерматит. Новые подходы к терапии. Проблемы медицинской микологии. 2022;24(4):51–57. [Vashkevich AA, Suvorova AA, Raznatovskij KI, Reztsova PA, Gulordava MD, Levina YuV. Perioral dermatitis: new approaches to therapy. Problems of Medical Mycology. 2022;24(4):51–57. (In Russ.)] doi: 10.24412/1999-6780-2022-4-51-57
- Адаскевич В.П. Периоральный дерматит у детей. Педиатрия. Приложение к журналу ConsiliumMedicum. 2014;1:83–85. [Adaskevich VP. Perioral’nyj dermatit u detej. Pediatriya. Prilozhenie k zhurnalu ConsiliumMedicum. 2014;1:83–85. (In Russ.)]
- Байтяков В.В., Таратынова А.И., Власова С.А. Заболевания кожи лица у женщин фертильного возраста. Саратовский научно-медицинский журнал. 2020;16(1):34–38. [Bajtyakov VV, Taratynova AI, Vlasova SA. Face skin diseases at women of fertile age. Saratovskij nauchno-medicinskij zhurnal. 2020;16(1):34–38. (In Russ.)]
- Tolaymat L, Hall MR. Perioral Dermatitis. 2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
- Краснова Н.В., Гималиева Г.Г., Синицына Л.Г., Мисякова Т.Ю. Гранулематозный периоральный дерматит. Вестник дерматологии и венерологии. 2023;99(1):81–85. [Krasnova NV, Gimalieva GG, Sinicyna LG, Misyakova TY. Granulomatous perioral dermatitis. Vestnik Dermatologii i Venerologii. 2023;99(1):81–85. (In Russ.)] doi: 10.25208/vdv1353
- Hoepfner A, Marsela E, Clanner-Engelshofen BM, Horvath ON, Sardy M, French LE, et al. Rosaceaandperioraldermatitis: asingle-center retrospective analysis of the clinical presentation of 1032 patients. J Dtsch Dermatol Ges. 2020;18(6):561–570. doi: 10.1111/ddg.14120
- Кубанов А.А., Галлямова Ю.А., Гревцева А.С. Роль клещей Demodex в развитии папуло-пустулезных дерматозов. Экспериментальная и клиническая дерматокосметология. 2014;2:43–46. [Kubanov AA, Gallyamova YuA, Grevceva AS. Rol’ kleshchej Demodex v razvitii papulo-pustuleznyh dermatozov. Eksperimental’naya i klinicheskaya dermatokosmetologiya. 2014;2:43–46. (In Russ.)]
- Соколова Т.В., Голицына М.В., Малярчук А.П., Ильина И.В. Роль клещей рода Demodex в патогенезе дерматозов фациальной локализации. Вестник Медицинского института непрерывного образования. 2022;1:30–36. [Sokolova TV, Golitsyna MV, Malyarchuk AP, Ilyina IV. The role of Demodex mites in the pathogenesis of the dermatosis of facial localization. Bulletin of the Medical Institute of Сontinuing Education 2022;1:30–36. (In Russ.)] doi: 10.46393/27821714_2022_1_30
- Do LHD, Azizi N, Maibach H. Sensitive Skin Syndrome: An Update. Am J Clin Dermatol. 2020;21(3):401–409. doi: 10.1007/s40257-019-00499-7
- Parke L, Diernaes J, Bygum A. Papulopustular Facial Eruption in a Child: A Quiz. Acta Derm Venereol. 2019;99(7):709–710. doi: 10.2340/00015555-3159
- Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, et al. The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions. Microorganisms. 2019;7(11):550. doi: 10.3390/microorganisms7110550
- Saunte DML, Gaitanis G, Hay J. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. 2020;10:112. doi: 10.3389/fcimb.2020.00112
- Lee H, Kim KH. Treatment of pediatric periorificial dermatitis with topicalcal cineurin inhibitor and topical/oral metronidazole. J Dermatol. 2021;48(3):405–407. doi: 10.1111/1346-8138.15695
- Ollech A, Yousif R, Kruse L, Wagner A, Kenner-Bell B, Chamlin S, et al. Topical calcineurin inhibitors for pediatric periorificial dermatitis. J Am Acad Dermatol. 2020;82(6):1409–1414. doi: 10.1016/j.jaad.2020.01.064
- Инструкция к препарату метронидазол гель для наружного применения. URL: https://apteka.ru/chelyabinsk/product/metronidazol-1-gel-dlya-naruzhnogo-primeneniya-30-gr-5e32658265b5ab000164fa9c/
- Charnowski S, Wollenberg A, Reinholz M. Perioral dermatitis successfully treated with topical ivermectin. Ann Dermatol. 2019;31(Suppl):S27–S28. doi: 10.5021/ad.2019.31.S.S27
- Gray NA, Tod B, Rohwer A, Fincham L, Visser WI, McCaul M. Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: A systematic review. J Eur Acad Dermatol Venereol. 2022;36(3):380–390. doi: 10.1111/jdv.17817
- Заславский Д.В., Баринова А.Н., Плавинский С.Л. Синдром отмены топических кортикостероидов: симптомы, признаки и подходы к лечению. Практика педиатра. 2022;3:27–34. [Zaslavsky DV, Barinova AN, Plavinsky SL. Topical corticosteroid withdrawal syndrome: symptoms, signs and treatment approaches. Pediatrician’s Practice. 2022;3:27–34. (In Russ.)]
- Перламутров Ю.Н., Ольховская К.Б. Лечение «дерматита отмены» после применения топических глюкокортикостероидов с использованием активированного цинка пиритиона. Вестник дерматологии и венерологии. 2011;6:63–67. [Perlamutrov YuN, Ol’hovskaya KB. Lechenie “dermatita otmeny” posle primeneniya topicheskih glyukokortikosteroidov s ispol’zovaniem aktivirovannogo cinka piritiona. Vestnik Dermatologii i Venerologii. 2011;6:63–67. (In Russ.)]
- Инструкция к препарату скин-кап. URL: https://medi.ru/instrukciya/skin-kap-krem_16236/
- Park M, Cho YJ, Lee YW, Jung WH. Understanding the Mechanism of Action of the Anti-Dandruff Agent Zinc Pyrithione against Malassezia restricta. Sci Rep. 2018;8(1):12086. doi: 10.1038/s41598-018-30588-2
Supplementary files
